Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Tissue Viability|May 10, 2026
Facilitators and barriers to delayed medical-seeking in adults with pressure injuries: a qualitative studyJiayun Lu, Yi Zhang, Xianhua Cai, et al.
Molecular Carcinogenesis|March 10, 2017
Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemopreventionNing Zheng, Jiahang Chen, Tao Li, et al.
Chemical Communications (Cambridge, England)|August 12, 2021
Self-powered and low-temperature resistant MXene-modified electronic-skin for multifunctional sensingMinmin Wang, Weiqun Liu, Xu Shi, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 18, 2016
Biallelic and Triallelic 5-Hydroxytyramine Transporter Gene-Linked Polymorphic Region (5- HTTLPR) Polymorphisms and Their Relationship with Lifelong Premature Ejaculation: A Case-Control Study in a Chinese PopulationYuanyuan Huang, Xiansheng Zhang, Jingjing Gao, et al.
Oncotarget|September 24, 2017
Mifepristone inhibits ovarian cancer metastasis by intervening in SDF-1/CXCR4 chemokine axisNing Zheng, Jiahang Chen, Weiqun Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 2, 2019
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenibNing Zheng, Weiqun Liu, Bifei Li, et al.
Molecular Plant-Microbe Interactions : MPMI|March 21, 2020
Identification of a Novel <i>NtLRR-RLK</i> and Biological Pathways That Contribute to Tolerance of TMV in <i>Nicotiana tabacum</i>Jing Wang, Fengsheng Hao, Kunfeng Song, et al.
Molecular Carcinogenesis|September 28, 2018
CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancerNing Zheng, Weiqun Liu, Jiahang Chen, et al.
Pageof 5